Valuation: Edwards Lifesciences Corporation

Market Cap 52.9B 284B 47.46B 43.88B 39.74B 74.25B 5,038B 75.15B 525B 209B 2,637B 199B 194B 8,370B P/E 2026 *
36.4x
P/E 2027 * 27.8x
Enterprise Value 49.27B 265B 44.21B 40.87B 37.01B 69.15B 4,693B 69.99B 489B 195B 2,456B 185B 181B 7,795B EV / Sales 2026 *
7.29x
EV / Sales 2027 * 6.42x
Free-Float
86.96%
Yield 2026 *
-
Yield 2027 * -
1 day-8.30%
Current month-8.30%
1 month-8.30%
3 months-1.14%
6 months-0.81%
Current year-12.04%
1 month 104.5
Extreme 104.5
104.5
Current year 94.3
Extreme 94.3
122.51
1 year 94.3
Extreme 94.3
122.51
3 years 78.32
Extreme 78.32
129.61
5 years 76.4
Extreme 76.4
185.9
10 years 75.1
Extreme 75.101666
316
Manager TitleAgeSince
Chief Executive Officer 58 2023-05-10
Director of Finance/CFO 43 2026-05-28
Chief Tech/Sci/R&D Officer 51 2025-08-31
Director TitleAgeSince
Chairman 69 2024-05-06
Director/Board Member 62 2015-02-09
Director/Board Member 58 2023-05-10
Change 5-day change 1-year change 3-year change Capi.($)
-8.30%0.00% - - 52.35B
+1.61%+2.44%+24.90%+63.22% 256B
+0.89%+4.38%+5.91%+24.58% 163B
-0.38%+1.41%-19.42%+71.51% 155B
-5.84%-6.91%-58.58%-14.32% 65.3B
+1.06%+3.95%+13.56%+48.73% 52.35B
+1.72%+2.78%-13.92%-7.13% 51.93B
+1.39%-0.27%+7.48%+67.70% 50.75B
+2.25%+4.90%+23.80%+76.59% 50.04B
+1.78%+7.69%+35.57%+94.84% 46.03B
Average -0.22%+1.74%+2.14%+47.30% 98.94B
Weighted average by Cap. +0.37%+1.68%+4.17%+49.58%

Financials

2026 *2027 *
Net sales 6.76B 36.33B 6.07B 5.61B 5.08B 9.49B 644B 9.6B 67.05B 26.71B 337B 25.37B 24.84B 1,070B 7.43B 39.93B 6.67B 6.16B 5.58B 10.43B 708B 10.56B 73.7B 29.35B 370B 27.88B 27.3B 1,176B
Net income 1.46B 7.84B 1.31B 1.21B 1.1B 2.05B 139B 2.07B 14.46B 5.76B 72.68B 5.47B 5.36B 231B 1.88B 10.11B 1.69B 1.56B 1.41B 2.64B 179B 2.67B 18.66B 7.43B 93.78B 7.06B 6.91B 298B
Net Debt -3.63B -19.51B -3.26B -3.01B -2.73B -5.1B -346B -5.16B -36.01B -14.34B -181B -13.63B -13.34B -574B -5.19B -27.91B -4.66B -4.31B -3.9B -7.29B -495B -7.38B -51.52B -20.52B -259B -19.49B -19.08B -822B
Projected Income Statement - Annual - Edwards Lifesciences Corporation
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Edwards Lifesciences Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
30
Last Close Price
90.82USD
Average target price
101.39USD
Spread / Average Target
+11.63%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Edwards Lifesciences Corporation